These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18339758)

  • 1. Modeling the influence of the E-cadherin-beta-catenin pathway in cancer cell invasion: a multiscale approach.
    Ramis-Conde I; Drasdo D; Anderson AR; Chaplain MA
    Biophys J; 2008 Jul; 95(1):155-65. PubMed ID: 18339758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From genotypes to phenotypes: classification of the tumour profiles for different variants of the cadherin adhesion pathway.
    Ramis-Conde I; Drasdo D
    Phys Biol; 2012 Jun; 9(3):036008. PubMed ID: 22683697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cadherin-catenin complex: protein interactions and their implications for cadherin function.
    Aberle H; Schwartz H; Kemler R
    J Cell Biochem; 1996 Jun; 61(4):514-23. PubMed ID: 8806074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin.
    Wong AS; Gumbiner BM
    J Cell Biol; 2003 Jun; 161(6):1191-203. PubMed ID: 12810698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer.
    Schmalhofer O; Brabletz S; Brabletz T
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):151-66. PubMed ID: 19153669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
    Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
    Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant progression of invasive tumour cells seen in hypoxia present an accumulation of beta-catenin in the nucleus at the tumour front.
    Demir R; Dimmler A; Naschberger E; Demir I; Papadopoulos T; Melling N; Sturzl M; Hohenberger W
    Exp Mol Pathol; 2009 Oct; 87(2):109-16. PubMed ID: 19481539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK.
    Conacci-Sorrell M; Simcha I; Ben-Yedidia T; Blechman J; Savagner P; Ben-Ze'ev A
    J Cell Biol; 2003 Nov; 163(4):847-57. PubMed ID: 14623871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of exon 8 increases cisplatin-induced E-cadherin cleavage.
    Fuchs M; Hermannstädter C; Hutzler P; Häcker G; Haller F; Höfler H; Luber B
    Exp Cell Res; 2008 Jan; 314(1):153-63. PubMed ID: 17959171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of epithelial to mesenchymal transition in colorectal carcinoma by regulation of the E-cadherin-β-catenin-vinculin axis.
    Pal I; Rajesh Y; Banik P; Dey G; Dey KK; Bharti R; Naskar D; Chakraborty S; Ghosh SK; Das SK; Emdad L; Kundu SC; Fisher PB; Mandal M
    Cancer Lett; 2019 Jun; 452():254-263. PubMed ID: 30904616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of phosphatidylinositol 3-kinase/Akt signaling by EGF downregulates membranous E-cadherin and β-catenin and enhances invasion in nasopharyngeal carcinoma cells.
    Yip WK; Seow HF
    Cancer Lett; 2012 May; 318(2):162-72. PubMed ID: 22182447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of E-cadherin and β-catenin in two cholangiocarcinoma cell lines (OZ and HuCCT1) with different degree of invasiveness of the primary tumor.
    Abuetabh Y; Persad S; Nagamori S; Huggins J; Al-Bahrani R; Sergi C
    Ann Clin Lab Sci; 2011; 41(3):217-23. PubMed ID: 22075503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen type I regulates beta-catenin tyrosine phosphorylation and nuclear translocation to promote migration and proliferation of gastric carcinoma cells.
    Li A; Zhou T; Guo L; Si J
    Oncol Rep; 2010 May; 23(5):1247-55. PubMed ID: 20372837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cadherin-mediated cell-cell interactions in normal and cancer cells.
    Gloushankova NA; Rubtsova SN; Zhitnyak IY
    Tissue Barriers; 2017 Jul; 5(3):e1356900. PubMed ID: 28783415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin is required for the proper activation of the Lifr/Gp130 signaling pathway in mouse embryonic stem cells.
    del Valle I; Rudloff S; Carles A; Li Y; Liszewska E; Vogt R; Kemler R
    Development; 2013 Apr; 140(8):1684-92. PubMed ID: 23487312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Theoretical Model of the Wnt Signaling Pathway in the Epithelial Mesenchymal Transition.
    Gasior K; Hauck M; Wilson A; Bhattacharya S
    Theor Biol Med Model; 2017 Oct; 14(1):19. PubMed ID: 28992816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells.
    Näthke IS; Hinck L; Swedlow JR; Papkoff J; Nelson WJ
    J Cell Biol; 1994 Jun; 125(6):1341-52. PubMed ID: 8207062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory Leukocyte Protease Inhibitor (SLPI) expression downregulates E-cadherin, induces β-catenin re-localisation and triggers apoptosis-related events in breast cancer cells.
    Rosso M; Lapyckyj L; Amiano N; Besso MJ; Sánchez M; Chuluyan E; Vazquez-Levin MH
    Biol Cell; 2014 Sep; 106(9):308-22. PubMed ID: 25039920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl- glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro.
    Steelant WF; Goeman JL; Philippé J; Oomen LC; Hilkens J; Krzewinski-Recchi MA; Huet G; Van der Eycken J; Delannoy P; Bruyneel EA; Mareel MM
    Int J Cancer; 2001 May; 92(4):527-36. PubMed ID: 11304687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.